Jing Chen

Mrs. Jing Chen

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2016 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
TWTing Wang
Ting Wang
JCJing Chen
Jing Chen
CTChuan-Xi Tang
Chuan-Xi Tang
XZXiao-Yan Zhou
Xiao-Yan Zhou
DGDian-Shuai Gao
Dian-Shuai Gao

1 August 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MCMa Chengcheng
Ma Chengcheng
APAn Panpan
An Panpan
YYYan Yalong
Yan Yalong
SMSu Mingyu
Su Mingyu
XWXu Wei
Xu Wei
CTCHUANXI TANG
CHUANXI TANG
The core of clinic treatment of Parkinson's disease (PD) is to enhance dopamine (DA) signaling within the brain. The regulation of dopamine transporter (DAT) is integral to this process. This study aims to explore the regulatory mechanism of glial cell line-derived neurotrophic factor (GDNF) on DAT, thereby gaining a profound understanding its potential value in treating PD. In this study, we investigated the effects of GDNF on both cellular and mouse models of PD, including the glycosylation and membrane transport of DAT detected by immunofluorescence and immunoblotting, DA signal measured by neurotransmitter fiber imaging technology, Golgi morphology observed by electron microscopic, as well as cognitive ability assessed by behavior tests. This study revealed that in animal trials, MPTP-induced Parkinson's Disease (PD) mice exhibited a marked decline in cognitive function. Utilizing ELISA and neurotransmitter fiber imaging techniques, we observed a decrease in dopamine levels and a significant reduction in the intensity of dopamine signal release in the Prefrontal Cortex (PFC) of PD mice induced by MPTP. Intriguingly, these alterations were reversed by Glial Cell Line-Derived Neurotrophic Factor (GDNF). In cellular experiments, following MPP + intervention, there was a decrease in Gly-DAT modification in both the cell membrane and cytoplasm, coupled with an increase in Nongly-DAT expression and aggregation of DAT within the cytoplasm. Conversely, GDNF augmented DAT glycosylation and facilitated its membrane transport in damaged dopaminergic neurons, concurrently reversing the effects of GRASP65 depletion and Golgi fragmentation, thereby reducing the accumulation of DAT in the Golgi apparatus. Furthermore, overexpression of GRASP65 enhanced DAT transport in PD cells and mice, while suppression of GRASP65 attenuated the efficacy of GDNF on DAT. Additionally, GDNF potentiated the reutilization of neurotransmitters by the PFC presynaptic membrane, boosting the effective release of dopamine following a single electrical stimulation, ultimately ameliorating the cognitive impairments in PD mice.Therefore, we propose that GDNF enhances the glycosylation and membrane trafficking of DAT by facilitating the re-aggregation of the Golgi apparatus, thereby amplifying the utilization of DA signals. This ultimately leads to the improvement of cognitive abilities in PD mouse models. Our study illuminates, from a novel angle, the beneficial role of GDNF in augmenting DA utilization and cognitive function in PD, providing fresh insights into its therapeutic potential.

6 June 2025 in Probiotics and Antimicrobial Proteins
Verified
Journal Article
Closed access
PDF file
PAP. P. An
P. P. An
XLX. Y. Liang
X. Y. Liang
XYX. Y. Yao
X. Y. Yao
ZLZ. H. Liao
Z. H. Liao
YTY. C. Tang
Y. C. Tang
JCJing Chen
Jing Chen

1 February 2012 in Brain Research
Verified
Journal Article
Closed access
YSYu H. Sun
Yu H. Sun
XHXiangui Huang
Xiangui Huang
MLMeiying Liu
Meiying Liu
JCJunping Cao
Junping Cao
JCJing Chen
Jing Chen
DGDian-Shuai Gao
Dian-Shuai Gao

23 July 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
JCJing Chen
Jing Chen
YLYifang Liu
Yifang Liu
MSMingyu Su
Mingyu Su
YSYaoyu Sun
Yaoyu Sun
CLChenkai Liu
Chenkai Liu
CTCHUANXI TANG
CHUANXI TANG
This study focused on α-synuclein (α-syn) aggregation in the dorsomedial striatum (DMS) so as to investigate its role in the cognitive flexibility of Parkinson’s disease (PD). Here, we investigated the cognitive flexibility by assessing reversal learning abilities in MPTP-induced subacute PD model mice and in C57BL/6J mice with α-syn aggregation in the DMS induced by adenovirus (AAV-SNCA) injection, followed by an analysis of the target protein’s expression and distribution. PD mice exhibited impairments in reversal learning, positively correlated with the expression of phosphorylated α-syn in the DMS. Furthermore, the mice in the AAV-SNCA group exhibited reversal learning deficits and a reduction in acetylcholine levels, accompanied by protein alterations within the DMS. Notably, the administration of a muscarinic receptor 1 (M1R) agonist was able to alleviate the aforementioned phenomenon. These findings suggest that the impaired cognitive flexibility in PD may be attributed to the diminished activation of acetylcholine to M1R caused by α-syn aggregation.

21 August 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JCJing Chen
Jing Chen
ZLZhi Ling
Zhi Ling
MLMaokang Lv
Maokang Lv
SCShengzhe Chen
Shengzhe Chen
WXWei Xu
Wei Xu
CTCHUANXI TANG
CHUANXI TANG
Dopamine (DA) transmission from the ventral tegmental area (VTA) to the nucleus accumbens (NAc) is strongly associated with depression in Parkinson’s disease (PD). Decreased DA levels due to alpha-synuclein (α-syn) aggregation have been underappreciated in relation to depression in PD. This study investigated the role of VTA-related α-syn aggregation in depression of PD, and whether gial cell line-derived neurotrophic factor (GDNF) can inhibit α-syn aggregation to improve symptoms. Here, α-syn aggregation and GDNF overexpression were induced in the VTA of 8-week-old male mice (C57BL/6J, DAT-cre, D2-cre) using adeno-associated viruses, combined with a cis-tracer virus as well as a chemogenetic virus. Behavioral tests, immunofluorescence (IF), western blot (WB), and enzyme-linked immunosorbent assay (ELISA) were employed for analysis. The mice with increased p-α-syn in VTA exhibited depressive-like behavior, along with reduced DA levels in the VTA and NAc, as well as reduced expression of related proteins in the NAc. However, GDNF overexpression in the VTA, led to a decrease in p-α-syn expression and reversed the aforementioned phenomena. Furthermore, results from cis-tracer virus and Immunofluorescence (IF) assay revealed a reduction in transmission of DA from the VTA to the NAc in mice with α-syn aggregation, which can be reversed by GDNF overexpression. Additionally, chemogenetic virus-induced diminished D2-MSN activation in the NAc significantly ameliorated depression-like behavior due to α-syn aggregation in the VTA. In conclusion, the aggregation of α-syn within the VTA may contribute to depression in PD, while GDNF can alleviate depression by inhibiting α-syn aggregation.